These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36925319)

  • 1. Sarcopenia is a negative predictive factor for endoscopic remission in patients with Crohn's disease treated with biologics.
    Grova M; Crispino F; Maida M; Vitello A; Renna S; Casà A; Tesè L; Macaluso FS; Orlando A
    Dig Liver Dis; 2023 Jul; 55(7):865-871. PubMed ID: 36925319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia measurements and clinical outcomes in Crohn's disease surgical patients.
    Hong JT; James S; Tran A; Kutaiba N
    ANZ J Surg; 2022 Dec; 92(12):3209-3213. PubMed ID: 36156838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience.
    D'Amico F; Tasopoulou O; Fiorino G; Zilli A; Furfaro F; Allocca M; Sileri P; Spinelli A; Peyrin-Biroulet L; Danese S
    Inflamm Bowel Dis; 2023 Apr; 29(4):539-547. PubMed ID: 35640113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of adipose tissue for predicting Crohn's disease postoperative endoscopic recurrence and anastomotic ulcer.
    Yang L; Liu G; Zhang Y; Yao B; Wu Q; Peng L; Wang X; Yuan L
    Int J Colorectal Dis; 2023 Jun; 38(1):170. PubMed ID: 37328584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of biological agent on body composition in patients with Crohn's disease.
    Choi EJ; Baek DH; Lee HS; Song GA; Kim TO; Park YE; Lee CM; ; Lee JH
    BMC Gastroenterol; 2023 Mar; 23(1):100. PubMed ID: 36997863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia hinders the decline in disease activity after surgery for people with Crohn's disease: Preliminary results.
    Yasueda A; Sekido Y; Takeda T; Ogino T; Miyoshi N; Takahashi H; Uemura M; Doki Y; Eguchi H; Mizushima T
    Nutrition; 2022 Feb; 94():111526. PubMed ID: 34861460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study.
    Dragoni G; Castiglione F; Bezzio C; Pugliese D; Spagnuolo R; Viola A; Cocomazzi F; Aratari A; Savarino EV; Balestrieri P; Onali S; Viganò C; Ribaldone DG; Innocenti T; Testa A; Saibeni S; Privitera G; Milla M; Armuzzi A; Fantini MC; Fiorino G
    United European Gastroenterol J; 2023 Apr; 11(3):271-281. PubMed ID: 36942657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Sarcopenia on Clinical Course of Inflammatory Bowel Disease in Korea.
    Nam K; Lee JY; Ko Y; Kim KW; Lee HS; Hong SW; Park JH; Hwang SW; Yang DH; Ye BD; Byoun JS; Myung SJ; Yang SK; Park SH
    Dig Dis Sci; 2023 Jun; 68(6):2165-2179. PubMed ID: 36693962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics.
    Inokuchi T; Takahashi S; Hiraoka S; Toyokawa T; Takagi S; Takemoto K; Miyaike J; Fujimoto T; Higashi R; Morito Y; Nawa T; Suzuki S; Nishimura M; Inoue M; Kato J; Okada H
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1329-1336. PubMed ID: 30724387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing.
    Castiglione F; Imperatore N; Testa A; De Palma GD; Nardone OM; Pellegrini L; Caporaso N; Rispo A
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1026-1039. PubMed ID: 30854708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
    Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
    Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease.
    Hoekman DR; Stibbe JA; Baert FJ; Caenepeel P; Vergauwe P; De Vos M; Hommes DW; Benninga MA; Vermeire SA; D'Haens GR;
    J Crohns Colitis; 2018 Apr; 12(5):517-524. PubMed ID: 29401297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ulcer Size After Induction Therapy Performs Better Than Symptom Assessment for Prediction of One Year Endoscopic Remission in Crohn's Disease: A Post Hoc Analysis.
    Pray C; Wong ECL; Aruljothy A; Dulai PS; Marshall JK; Reinisch W; Narula N
    Inflamm Bowel Dis; 2023 Aug; 29(8):1263-1271. PubMed ID: 36179118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Evaluation of the Achievement of Mucosal Healing with Anti-TNF-α Therapy in a Paediatric Crohn's Disease Cohort.
    Nuti F; Civitelli F; Bloise S; Oliva S; Aloi M; Latorre G; Viola F; Cucchiara S
    J Crohns Colitis; 2016 Jan; 10(1):5-12. PubMed ID: 26188350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for digestive tract cancer: A prospective cohort study.
    Zhang S; Tan S; Jiang Y; Xi Q; Meng Q; Zhuang Q; Han Y; Sui X; Wu G
    Clin Nutr; 2019 Dec; 38(6):2881-2888. PubMed ID: 30630709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of sarcopenia and its effect on prognosis in patients with Crohn's disease.
    Lee CH; Yoon H; Oh DJ; Lee JM; Choi YJ; Shin CM; Park YS; Kim N; Lee DH; Kim JS
    Intest Res; 2020 Jan; 18(1):79-84. PubMed ID: 32013316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Treat to Target Strategy Using Panenteric Capsule Endoscopy in Pediatric Patients With Crohn's Disease.
    Oliva S; Aloi M; Viola F; Mallardo S; Civitelli F; Maccioni F; Hassan C; Papoff P; Cucchiara S; Cohen SA
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2060-2067.e1. PubMed ID: 30326301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease.
    Subramaniam K; Fallon K; Ruut T; Lane D; McKay R; Shadbolt B; Ang S; Cook M; Platten J; Pavli P; Taupin D
    Aliment Pharmacol Ther; 2015 Mar; 41(5):419-28. PubMed ID: 25580985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience.
    Suárez Ferrer C; González-Lama Y; González-Partida I; Calvo Moya M; Vera Mendoza I; Matallana Royo V; Arevalo Serrano J; Abreu Garcia L
    Dig Dis Sci; 2019 Mar; 64(3):875-879. PubMed ID: 30542812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.